Message from the CEO

Victor E. Clarke Miami Cancer Institute Charitable Foundation2019 – 2020 2019 IMPACT REPORT Highlights

Dear Friends of Miami Cancer Institute,

I’m pleased to share Miami Cancer Institute’s 2019 successes with you. Since opening in 2017, we have created an innovative academic-community cancer center with experts who are discovering new ways to prevent, diagnose and treat cancer. Our patients, whether from South Florida or points far beyond, are always our priority. As we continue to develop sophisticated treatment plans for our patients, we are dedicated to providing an outstanding patient experience that considers each individual’s needs.

In 2019, we experienced an exciting year of growth and milestones. We added new services and technologies, offered new clinical trials and, recently brought the Lynn Cancer Institute at Boca Raton Regional Hospital into our family. We cared for 33,000 patients in 2019, a 12 percent increase since 2018, and saw significant increases in the number of surgeries and procedures, as well as radiation treatments and chemotherapy infusions. In November, we celebrated our 500th patient treated in our Proton Therapy Center, one of the few cancer centers in the United States, and the first in South Florida, offering this most technologically advanced method of radiation therapy. Highlights also included the opening of our Molecular Diagnostics Laboratory and the addition of allogeneic transplants to our Blood and Marrow Transplant program. We launched our Multidisciplinary Skin Cancer Clinic, the Benign Breast Clinic, and our Cardio-Oncology Referral Service in collaboration with Miami Cardiac & Vascular Institute. Our unparalleled compassion and patient services continued to provide support that allowed more patients to conquer and survive cancer. Through our Cancer Survivorship Clinic we offered a full range of services for children and adults who completed curative treatment, targeted the management of long-term cancer-related effects, as well as provided programs that promote a healthy lifestyle. Our strategic partnerships have been important to our success. As an affiliate of Memorial Sloan Kettering, we have adopted the latest standards of care and increased patient access to clinical trials. We also launched research partnerships with Florida International, ensuring we train and mentor the next generation of surgeons. We could not achieve such ambitious goals without generous philanthropic support. Thank you for joining us in our quest to change the future of cancer care for good.

Michael J. Zinner, M.D.

Chief Executive Officer & Executive Medical Director, Miami Cancer Institute